Peter Hoskin

43.5k total citations · 7 hit papers
584 papers, 22.2k citations indexed

About

Peter Hoskin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Radiation. According to data from OpenAlex, Peter Hoskin has authored 584 papers receiving a total of 22.2k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Pulmonary and Respiratory Medicine, 218 papers in Surgery and 156 papers in Radiation. Recurrent topics in Peter Hoskin's work include Advanced Radiotherapy Techniques (156 papers), Management of metastatic bone disease (129 papers) and Prostate Cancer Diagnosis and Treatment (101 papers). Peter Hoskin is often cited by papers focused on Advanced Radiotherapy Techniques (156 papers), Management of metastatic bone disease (129 papers) and Prostate Cancer Diagnosis and Treatment (101 papers). Peter Hoskin collaborates with scholars based in United Kingdom, United States and Netherlands. Peter Hoskin's co-authors include Ana M. Rojas, Michele I. Saunders, Peter Ostler, Linda Bryant, G.W. Hanks, Gerry Lowe, Søren M. Bentzen, Peter Bownes, Edward Chow and David C. Linch and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Peter Hoskin

559 papers receiving 21.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Palliative Radiotherapy for Bone Metastases: An ASTRO Evidence-Based Guideline

2011 571 citations Peter Hoskin et al. International Journal of Radiation Oncology*Biology*Physics profile →
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

2010 555 citations Peter Hoskin et al. profile →
Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines

2018 529 citations Peter Hoskin et al. profile →
Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma

2015 407 citations John Radford, Tim Illidge et al. profile →
Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer

2012 372 citations Peter Hoskin, Ana M. Rojas et al. profile →
Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

2014 290 citations Peter Hoskin et al. profile →
Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer

2016 244 citations Peter Hoskin, Søren M. Bentzen et al. profile →

Peers

Countries citing papers authored by Peter Hoskin

Since Specialization

Citations

This map shows the geographic impact of Peter Hoskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hoskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hoskin more than expected).

Fields of papers citing papers by Peter Hoskin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hoskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hoskin. The network helps show where Peter Hoskin may publish in the future.

Co-authorship network of co-authors of Peter Hoskin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hoskin. A scholar is included among the top collaborators of Peter Hoskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hoskin. Peter Hoskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development and refinement of patient care recommendations in brachytherapy for locally advanced cervical cancer using nominal group technique workshops 2024 ·Supportive Care in Cancer ·(unknown), Emma Dures, Peter Hoskin, Jenny Johnston, Louise Reardon, Fiona Cramp	0
2	Half body irradiation (HBI) for bone metastases in the modern radiotherapy technique era – A systematic review 2024 ·Clinical and Translational Radiation Oncology ·(unknown), (unknown), (unknown), Peter Hoskin, (unknown), Giulia Marvaso, (unknown), (unknown), (unknown), (unknown), (unknown), Jacek Fijuth, (unknown)	2
3	Radiobiology and modelling in Brachytherapy: A review inspired by the ESTRO Brachytherapy pre-meeting course 2024 ·Clinical and Translational Radiation Oncology ·Alexandra Stewart, (unknown), (unknown), (unknown), José Luis Guinot, Taran Paulsen Hellebust, Peter Hoskin, Christian Kirisits, (unknown), Frank‐André Siebert, Luca Tagliaferri, (unknown), Dorin Todor, (unknown), Jean‐Michel Hannoun‐Lévi	2
4	The Use of Artificial Intelligence Technologies in Cancer Care 2024 ·Clinical Oncology ·Peter Hoskin	1
5	The clinical application of in vivo dosimetry for gynaecological brachytherapy: A scoping review 2024 ·Technical Innovations & Patient Support in Radiation Oncology ·(unknown), (unknown), Gerry Lowe, Eliana Vásquez Osorio, (unknown), Peter Hoskin	1
6	Impact of Multiprofessional Radiotherapy Peer Review on Multidisciplinary Team Meeting Staging in Head and Neck Cancer 2024 ·Clinical Oncology ·(unknown), Amit Gupta, Thalia Afxentiou, (unknown), Ruhi Kanani, (unknown), Nikita Bhatt, Peter Hoskin, (unknown)	0
7	Involved Field Radiotherapy Versus No Further Treatment in Patients with Newly Diagnosed Stage 1A or 2A Hodgkin Lymphoma and a ‘Negative’ PET Scan after 3 Cycles ABVD. Survival and Cause of Death after a Median of 16 Years Follow-up in the UK RAPID Trial 2024 ·Blood ·John Radford, (unknown), (unknown), Ruth Pettengell, Peter Johnson, Peter Hoskin, Tim Illidge, Nicholas Counsell	0
8	Real World Multi-Institutional Outcomes of Bladder Carbogen and Nicotinamide (BCON) in Muscle-Invasive Bladder Cancer (MIBC) 2023 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), (unknown), (unknown), (unknown), (unknown), Ashok Nikapota, (unknown), Gaurav Kapur, Peter Hoskin, (unknown)	1
9	Prognostic Factors for Survival with Metastatic Spinal Cord Compression in the SCORAD Randomized Trial 2020 ·International Journal of Radiation OncologyBiologyPhysics ·Peter Hoskin, Andre Lopes, Allan Hackshaw	1
10	Prognostication for Advanced Stage Hodgkin Lymphoma (HL) in the Modern Era: A Project from the Hodgkin Lymphoma International Study for Individual Care (HoLISTIC) Consortium 2020 ·Blood ·Angie Mae Rodday, Susan K. Parsons, (unknown), Ranjana H. Advani, Massimo Federico, Jonathan W. Friedberg, Andrea Gallamini, David Hodgson, Peter Hoskin, Martin Hutchings, Peter Johnson, Kara M. Kelly, Brian K. Link, John Radford, Pier Luigi Zinzani, James R. Cerhan, John Raemaekers, Andrew M. Evens	3
11	A Gene Signature for Selecting Benefit from Hypoxia Modification of Radiotherapy for High-Risk Bladder Cancer Patients 2017 ·Clinical Cancer Research ·Lingjian Yang, Janet Taylor, Amanda Eustace, Joely J. Irlam, Helen Denley, Peter Hoskin, Jan Alsner, Francesca M. Buffa, Adrian L. Harris, Ananya Choudhury, Catharine West	89
12	Molecular Subtyping of Muscle-Invasive Bladder Cancer Predicts Benefit of Hypoxia-Targeting Therapy 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Lingjian Yang, (unknown), Joely J. Irlam, (unknown), Peter Hoskin, Catharine West, Ananya Choudhury	4
13	A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer 2013 ·Clinical Cancer Research ·Amanda Eustace, Navin Mani, Paul N. Span, Joely J. Irlam, Janet Taylor, Guy Betts, Helen Denley, Crispin Miller, Jarrod J. Homer, Ana M. Rojas, Peter Hoskin, Francesca M. Buffa, Adrian L. Harris, Johannes H.A.M. Kaanders, Catharine West	167
14	FoRT: A Phase 3 Multi-Center Prospective Randomized Trial of Low Dose Radiation Therapy for Follicular and Marginal Zone Lymphoma 2012 ·International Journal of Radiation OncologyBiologyPhysics ·Peter Hoskin, Amy A. Kirkwood, (unknown), Caroline Brammer, Patricia Díez, Martin Robinson, Isabel Syndikus, Andrew Jack, Paul D. Smith	4
15	Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors 2011 ·Cancer Research ·Munitta Muthana, Athina Giannoudis, Simon D. Scott, Hsin‐Yu Fang, Seth B. Coffelt, (unknown), Craig Murdoch, Julian Burton, Neil A. Cross, B. F. Burke, (unknown), Freddie C. Hamdy, Nicola J. Brown, (unknown), Peter Hoskin, Magnus Essand, Claire E. Lewis, Norman J. Maitland	101
16	Effect of Epoetin Alfa on Survival and Cancer Treatment–Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer 2009 ·Journal of Clinical Oncology ·Peter Hoskin, Martin Robinson, N.J. Slevin, David Morgan, Kevin J. Harrington, Christopher Gaffney	44
17	Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244 2009 ·Journal of Clinical Oncology ·Peter Hoskin, Lisa Lowry, Alan Horwich, Andrew Jack, (unknown), Barry W. Hancock, Paul Smith, Wendi Qian, (unknown), Bilyana Popova, Andrew R. Pettitt, David Cunningham, Ruth Pettengell, John Sweetenham, David C. Linch, Peter Johnson	124
18	Randomized Phase III Trial of Radical Radiotherapy with Concurrent Carbogen and Nicotinamide in Locally-advanced Bladder Cancer 2009 ·International Journal of Radiation OncologyBiologyPhysics ·Peter Hoskin, Ana M. Rojas, Søren M. Bentzen, Megan I. Saunders, (unknown)	1
19	Evaluation of hypoxia within human prostate carcinoma using quantified bold MRI and pimonidazole immunohistochemical mapping 2003 ·UCL Discovery (University College London) ·Dawn Carnell, Rebekah E. Smith, Janet Taylor, (unknown), Peter Hoskin, (unknown)	1
20	Late complications of mantle radiotherapy for Hodgkin's lymphoma 2000 ·UCL Discovery (University College London) ·Amen Sibtain, Aaron Bradshaw, Nina Shah, Peter Hoskin	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact